[Glucose and lipid metabolic disorders in myasthenia gravis patients and its mechanisms].

Li, L J; Guan, Y Z; Lü, F; Song, Y W; Xu, X J; Jiang, Y; Wang, O; Xia, W B; Xing, X P; Li, M

Li, L J; Guan, Y Z; Lü, F; Song, Y W; Xu, X J; Jiang, Y; Wang, O; Xia, W B; Xing, X P; Li, M.

Afiliação

Li LJ; Department of Endocrinology, Key Laboratory of Endocrinology, National Health and Family Planning Commission, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China.
Guan YZ; Department of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Science & Peking Union Medical College, Beijing 100730, China.

Zhonghua Yi Xue Za Zhi ; 98(8): 581-586, 2018 Feb 27.

Article em Zh | MEDLINE | ID: mdl-29534385

Assuntos

Miastenia Gravis; Adulto; Glicemia; Estudos Transversais; Diabetes Mellitus Tipo 2; Feminino; Glucose; Força da Mão; Humanos; Insulina; Resistência à Insulina; Masculino; Pessoa de Meia-Idade

Palavras-chave

25-hydroxy vitamin D; Glucose and lipid metabolism; Insulin resistance; Myasthenia gravis; Osteocalcin

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Miastenia Gravis Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: Zh Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google